Exploring Prognostically Significant Factors in COVID-19-Associated Pulmonary Fibrosis after Adaptive Lung...

Area of Science:

• Pulmonology
• Infectious Diseases
• Radiology

Background:

• Hospitalized COVID-19 survivors often experience persistent symptoms and radiological abnormalities.
• Pulmonary fibrosis (PF) and oxygen dependence are anticipated long-term consequences for a significant number of patients.
• Understanding risk factors for fibrotic changes and CT correlates with functional outcomes is critical.

Purpose of the Study:

• To characterize persistent pulmonary consequences in patients after COVID-19 hospitalization.
• To identify clinical, radiological, and laboratory predictors of pulmonary fibrosis post-COVID-19.

Main Methods:

• Retrospective evaluation of 77 COVID-19 survivors treated between November and December 2020.
• High-resolution computed tomography (CT) assessment during acute phase and 6-8 months post-discharge.
• Classification into cohorts based on radiological fibrosis-like abnormalities versus disease resolution.

Main Results:

• Common CT findings included parenchymal cords, irregular interfaces, reticulation, and traction bronchiectasis.
• Pulmonary fibrosis-like changes persisted in 49.35% of patients at 6-8 months post-discharge.
• Age, BMI, high IL-6, low IO levels, and mechanical ventilation were prognostic indicators for persistent pulmonary fibrosis.

Conclusions:

• Pulmonary function can normalize in over half of COVID-19 patients by 8 months.
• A significant knowledge gap exists in managing long-term COVID-19 effects, particularly pulmonary fibrosis.
• Continued research and clinical trials are essential to address post-COVID-19 fibrosis and prevent mortality.